Beckman Coulter pens molecular diagnostics alliance
Beckman Coulter has launched a four-year collaboration with Irish University NUI Galway in the hope of speeding up molecular diagnostic tests.
Beckman Coulter has launched a four-year collaboration with Irish University NUI Galway in the hope of speeding up molecular diagnostic tests.
Novartis has announced the US approval of its first-in-class blood pressure med Tekturna (aliskiren) combined with a diuretic in a single-tablet formulation.
Bristol-Myers Squibb (BMS) has revealed plans to close another site in Puerto Rico in its latest cost-cutting move.
After seven months of offers, refusals and heated exchanges, it seems an increased offer from Roche has finally persuaded the powers that be at Ventana to sell up.
Dublin-based contract research organisation (CRO) Icon Clinical Research has forayed further into Eastern Europe with the opening of three new offices there.
Australian firm Fluorotechnics wants to bolster the sales of its proteomics products in Japan and so has signed up Osaka firm Wako Pure Chemical Industries to help.
Canadian vaccine specialist ImmunoVaccine Technologies (IVT) has scored a multi-million dollar grant to go towards developing its potent immune enhancement systems.
GE Healthcare has reported its fourth quarter and full year financial results in a tough 12 months that have seen the laboratory imaging and diagnostics company feel the full force of US Government regulatory pressure.